Mark J Massa, Age 625 Suncrest Dr, Collinsville, IL 62234

Mark Massa Phones & Addresses

5 Suncrest Dr, Collinsville, IL 62234 (618) 345-5269

Caseyville, IL

1132 Clinton Rd, Caseyville, IL 62232 (618) 345-5269

Madison, IL

Mentions for Mark J Massa

Mark Massa resumes & CV records

Resumes

Mark Massa Photo 37

Mark Massa Massa

Mark Massa Photo 38

Mark Massa

Mark Massa Photo 39

Mark Massa

Mark Massa Photo 40

Co Manager

Work:
Walmart
Co Manager
Mark Massa Photo 41

Mark Massa

Mark Massa Photo 42

Mark E Massa

Publications & IP owners

Wikipedia

Mark Massa Photo 46

Mark S. Massa

Mark S. Massa, SJ is the Dean of the Boston College School of Theology and Ministry and Karl Rahner Distinguished Professor of Theology at Fordham University in

Us Patents

Use Of Substituted N-Fused-Phenyl-N-Benzyl Aminoalcohol Compounds For Inhibiting Cholesteryl Ester Transfer Protein Activity

US Patent:
6448295, Sep 10, 2002
Filed:
Nov 14, 2001
Appl. No.:
09/991208
Inventors:
James A. Sikorski - Des Peres MO
Richard C. Durley - Chesterfield MO
Deborah A. Mischke - Defiance MO
Emily J. Reinhard - Chesterfield MO
Yvette M. Fobian - Labadie MO
Michael B. Tollefson - OFallon MO
Lijuan Wang - Wildwood MO
Margaret L. Grapperhaus - Troy IL
Brian S. Hickory - Wildwood MO
Mark A. Massa - Ballwin MO
Monica B. Norton - St. Louis MO
William F. Vernier - St. Louis MO
Barry L. Parnas - University City MO
Michele A. Promo - Chesterfield MO
Ashton T. Hamme - St. Louis MO
Dale P. Spangler - Deerfield MO
Melvin L. Rueppel - St. Louis MO
Assignee:
G.D. Searle Co. - Chicago IL
International Classification:
A61K 31136
US Classification:
514654, 514655, 514657, 514450, 514452, 514466, 514468, 564378, 564387, 564428, 564429, 549350, 549362, 549439, 549460
Abstract:
The invention relates to substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamine compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions and methods for treating atherosclerosis and other coronary artery diseases. Preferred tertiary-heteroalkylamine compounds are substituted N-fused-phenyl-N-benzyl aminoalcohols. A preferred specific N-fused-phenyl-N-benzyl aminoalcohol is the compound:.

Use Of Substituted N-Phenoxy-N-Phenyl Aminoalcohol Compounds For Inhibiting Cholesteryl Ester Transfer Protein Activity

US Patent:
6451823, Sep 17, 2002
Filed:
Nov 14, 2001
Appl. No.:
09/990645
Inventors:
James A. Sikorski - Des Peres MO
Richard C. Durley - Chesterfield MO
Deborah A. Mischke - Defiance MO
Emily J. Reinhard - Chesterfield MO
Yvette M. Fobian - Labadie MO
Michael B. Tollefson - OFallon MO
Lijuan Wang - Wildwood MO
Margaret L. Grapperhaus - Troy IL
Brian S. Hickory - Wildwood MO
Mark A. Massa - Ballwin MO
Monica B. Norton - St. Louis MO
William F. Vernier - St. Louis MO
Barry L. Parnas - University MO
Michele A. Promo - Chesterfield MO
Ashton T. Hamme - St. Louis MO
Dale P. Spangler - Deerfield IL
Melvin L. Rueppel - St. Louis MO
Assignee:
G.D. Searle Co. - Chicago IL
International Classification:
C07C23300
US Classification:
514351, 564184, 564300, 564310
Abstract:
The invention relates to use of substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamine compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions and methods for treating atherosclerosis and other coronary artery diseases. Preferred tertiary-heteroalkylamine compounds are substituted N-phenoxy-N-phenyl aminoalcohols. A preferred specific N-phenoxy-N-phenyl aminoalcohol is the compound:.

Use Of Substituted N,N-Disubstituted Non-Fused Heterocyclo Amino Compounds For Inhibiting Cholesteryl Ester Transfer Protein Activity

US Patent:
6451830, Sep 17, 2002
Filed:
Nov 14, 2001
Appl. No.:
09/991085
Inventors:
James A. Sikorski - Des Peres MO
Richard C. Durley - Chesterfield MO
Deborah A. Mischke - Defiance MO
Emily J. Reinhard - Chesterfield MO
Yvette M. Fobian - Labadie MO
Michael B. Tollefson - OFallon MO
Lijuan Wang - Wildwood MO
Margaret L. Grapperhaus - Troy IL
Brian S. Hickory - Wildwood MO
Mark A. Massa - Ballwin MO
Monica B. Norton - St. Louis MO
William F. Vernier - St. Louis MO
Barry L. Parnas - University City MO
Michele A. Promo - Chesterfield MO
Ashton T. Hamme - St. Louis MO
Dale P. Spangler - Deerfield IL
Melvin L. Rueppel - St. Louis MO
Assignee:
G.D. Searle Co. - Chicago IL
International Classification:
A61K 31421
US Classification:
514378, 5142268, 5142288, 514256, 514365, 514396, 514400, 544 53, 544 88, 544242, 544335, 548202, 548205, 548235, 5482731, 5482761
Abstract:
The invention relates to use of substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamine compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions and methods for treating atherosclerosis and other coronary artery diseases. Preferred tertiary-heteroalkylamine compounds are substituted N,N-disubstituted non-fused heterocyclo amines. A preferred specific N,N-disubstituted non-fused heterocyclo amine is the compound:.

Use Of Substituted N, N-Disubstituted Fused-Heterocyclo Amino Compounds For Inhibiting Cholesteryl Ester Transfer Protein Activity

US Patent:
6455519, Sep 24, 2002
Filed:
Nov 15, 2001
Appl. No.:
09/991116
Inventors:
James A. Sikorski - Des Peres MO
Richard C. Durley - Chesterfield MO
Deborah A. Mischke - Defiance MO
Emily J. Reinhard - Chesterfield MO
Yvette M. Fobian - Labadie MO
Michael B. Tollefson - OFallon MO
Lijuan Wang - Wildwood MO
Margaret L. Grapperhaus - Troy IL
Brian S. Hickory - Wildwood MO
Mark A. Massa - Ballwin MO
Monica B. Norton - St. Louis MO
William F. Vernier - St. Louis MO
Barry L. Parnas - University City MO
Michele A. Promo - Chesterfield MO
Ashton T. Hamme - St. Louis MO
Dale P. Spangler - Deerfield IL
Melvin L. Rueppel - St. Louis MO
Assignee:
G.D. SEarle Co. - Chicago IL
International Classification:
A61K 31536
US Classification:
51421109, 514183, 514221, 5142242, 5142305, 514249, 540468, 540473, 540552, 540569, 540573, 544 51, 544105, 544353
Abstract:
The invention relates to use of substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamine compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions and methods for treating atherosclerosis and other coronary artery diseases. Preferred tertiary-heteroalkylamine compounds are substituted N,N- disubstituted fused-heterocyclo amines. A preferred specific N,N-disubstituted fused-heterocyclo amine is the compound:.

Substituted N-Phenyl-N-Heteroaralkyl Aminoalcohol Compounds For Inhibiting Cholesteryl Ester Transfer Protein Activity

US Patent:
6458803, Oct 1, 2002
Filed:
Nov 23, 2001
Appl. No.:
09/991084
Inventors:
James A. Sikorski - Des Peres MO
Richard C. Durley - Chesterfield MO
Deborah A. Mischke - Defiance MO
Emily J. Reinhard - Chesterfield MO
Yvette M. Fobian - Labadie MO
Michael B. Tollefson - OFallon MO
Lijuan Wang - Wildwood MO
Margaret L. Grapperhaus - Troy IL
Brian S. Hickory - Wildwood MO
Mark A. Massa - Ballwin MO
Monica B. Norton - St. Louis MO
William F. Vernier - St. Louis MO
Barry L. Parnas - University City MO
Michele A. Promo - Chesterfield MO
Ashton T. Hamme - St. Louis MO
Dale P. Spangler - Deerfield IL
Melvin L. Rueppel - St. Louis MO
Assignee:
G.D. Searle Co. - Chicago IL
International Classification:
A61K 31426
US Classification:
514311, 514241, 514242, 514256, 514277, 514357, 514365, 514400, 514406, 514415, 514427, 514438, 514471, 514245, 514275, 514313, 514352, 514370, 514377, 514380, 514398, 514407, 514426, 514447, 514472, 544182, 544215, 544242, 544335, 544374, 544378, 544194, 544213, 544326, 544336, 544332, 546176, 546329, 546334, 546159, 546304, 546306, 548205, 548214, 548235, 5483355, 5483401, 5483751, 5483761, 548491, 548561, 548562, 548193, 548198, 548233, 5483311, 5483717, 5483725, 548483, 548557, 549 74, 549 78, 549491, 549497
Abstract:
The invention relates to substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamine compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions and methods for treating atherosclerosis and other coronary artery diseases. Preferred tertiary-heteroalkylamine compounds are substituted N-phenyl-N-heteroaralkyl aminoalcohols. A preferred specific N-phenyl-N-heteroaralkyl aminoalcohol is the compound:.

Use Of Substituted N,N-Disubstituted Mercapto Amino Compounds For Inhibiting Cholesteryl Ester Transfer Protein Activity

US Patent:
6458849, Oct 1, 2002
Filed:
Nov 14, 2001
Appl. No.:
09/991273
Inventors:
James A. Sikorski - Des Peres MO
Richard C. Durley - Chesterfield MO
Deborah A. Mischke - Defiance MO
Emily J. Reinhard - Chesterfield MO
Yvette M. Fobian - Labadie MO
Michael B. Tollefson - O Fallon MO
Lijuan Wang - Wildwood MO
Margaret L. Grapperhaus - Troy IL
Brian S. Hickory - Wildwood MO
Mark A. Massa - Ballwin MO
Monica B. Norton - St. Louis MO
William F. Vernier - St. Louis MO
Barry L. Parnas - University City MO
Michele A. Promo - Chesterfield MO
Ashton T. Hamme - St. Louis MO
Dale P. Spangler - Deerfield IL
Melvin L. Rueppel - St. Louis MO
Assignee:
G.D. Searle Co. - Chicago IL
International Classification:
A61K 31145
US Classification:
514649, 514654, 514655, 514658, 564374, 564381, 564382, 564384, 564389, 564390, 564391, 564392, 564440
Abstract:
The invention relates to use of substituted polycyclic aryl and heteroaryl -heteroalkyamine compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions and methods for treating atherosclerosis and other coronary artery diseases. Preferred -heteroalkylamine compounds are substituted N,N-disubstituted mercapto amines. A preferred specific N,N-disubstituted mercapto amine is the compound:.

Use Of Substituted N, N-Bis-Phenyl Aminoalcohol Compounds For Inhibiting Cholesteryl Ester Transfer Protein Activity

US Patent:
6458852, Oct 1, 2002
Filed:
Nov 14, 2001
Appl. No.:
09/991210
Inventors:
James A. Sikorski - Des Peres MO
Richard C. Durley - Chesterfield MO
Deborah A. Mischke - Defiance MO
Emily J. Reinhard - Chesterfield MO
Yvette M. Fobian - Labadie MO
Michael B. Tollefson - OFallon MO
Lijuan Wang - Wildwood MO
Margaret L. Grapperhaus - Troy IL
Brian S. Hickory - Wildwood MO
Mark A. Massa - Ballwin MO
Monica B. Norton - St. Louis MO
William F. Vernier - St. Louis MO
Barry L. Parnas - University City MO
Michele A. Promo - Chesterfield MO
Ashton T. Hamme - St. Louis MO
Dale P. Spangler - Deerfield IL
Melvin L. Rueppel - St. Louis MO
Assignee:
G.D. Searle Co. - Chicago IL
International Classification:
A61K 31135
US Classification:
514658, 564442
Abstract:
The invention relates to use of substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamine compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions and methods for treating atherosclerosis and other coronary artery diseases. Preferred tertiary-heteroalkylamine compounds are substituted N,N- bis-phenyl aminoalcohols. A preferred specific N,N-bis-phenyl aminoalcohol is the compound:.

Use Of Substituted N, N-Disubstituted Reverse Aminoalcohol Compounds For Inhibiting Cholesteryl Ester Transfer Protein Activity

US Patent:
6462092, Oct 8, 2002
Filed:
Nov 14, 2001
Appl. No.:
09/990811
Inventors:
James A. Sikorski - Des Peres MO
Richard C. Durley - Chesterfield MO
Deborah A. Mischke - Defiance MO
Emily J. Reinhard - Chesterfield MO
Yvette M. Fobian - Labadie MO
Michael B. Tollefson - OFallon MO
Lijuan Wang - Wildwood MO
Margaret L. Grapperhaus - Troy IL
Brian S. Hickory - Wildwood MO
Mark A. Massa - Ballwin MO
Monica B. Norton - St. Louis MO
William F. Vernier - St. Louis MO
Barry L. Parnas - University City MO
Michele A. Promo - Chesterfield MO
Ashton T. Hamme - St. Louis MO
Dale P. Spangler - Deerfield IL
Melvin L. Rueppel - St. Louis MO
Assignee:
G.D. Searle Co. - Chicago IL
International Classification:
A61K 31133
US Classification:
514655, 514649, 514654, 514658, 564374, 564381, 564382, 564384, 564389, 564390, 564392, 564447, 564391
Abstract:
The invention relates to use of substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamine compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions and methods for treating atherosclerosis and other coronary artery diseases. Preferred tertiary-heteroalkylamine compounds are substituted N,N-disubstituted reverse aminoalcohols. A preferred specific N,N-disubstituted reserve aminoalcohol is the compound:.

Isbn (Books And Publications)

Foundations Of Theological Study: A Sourcebook

Author:
Mark Massa
ISBN #:
0809132818

World Religions: A Sourcebook For Students Of Christian Theology

Author:
Mark Massa
ISBN #:
0809134616

Anti-Catholicism In America: The Last Acceptable Prejudice

Author:
Mark S. Massa
ISBN #:
0824523628

Charles Augustus Briggs And The Crisis Of Historical Criticism

Author:
Mark Stephen Massa
ISBN #:
0800670795

Catholics And American Culture: Fulton Sheen, Dorothy Day, And The Notre Dame Football Team

Author:
Mark Stephen Massa
ISBN #:
0824515374

Catholics And American Culture: Fulton Sheen, Dorothy Day, And The Notre Dame Football Team

Author:
Mark Stephen Massa
ISBN #:
0824519558

Anti-Catholicism In America: The Last Acceptable Prejudice

Author:
Mark Stephen Massa
ISBN #:
0824521293

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.